Lyndsay V. Rhodes, Ph.D.
Affiliations: | 2009 | Biomedical Sciences | Tulane University, New Orleans, LA, United States |
Area:
Cell Biology, Molecular BiologyGoogle:
"Lyndsay Rhodes"Parents
Sign in to add mentor| Matthew E. Burow | grad student | 2009 | Tulane | |
| (The effects of human mesenchymal stem cells on estrogen receptor positive breast carcinoma: Progression to hormone independence and metastasis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alim E, Stone L, Sharma N, et al. (2023) Single Live Cell Imaging of Multidrug Resistance Using Silver Ultrasmall Nanoparticles as Biosensing Probes in Triple-Negative Breast Cancer Cells. Acs Applied Bio Materials |
| Burks HE, Matossian MD, Rhodes LV, et al. (2021) ZEB2 regulates endocrine therapy sensitivity and metastasis in luminal a breast cancer cells through a non-canonical mechanism. Breast Cancer Research and Treatment |
| Matossian MD, Elliott S, Rhodes LV, et al. (2021) Application of a small molecule inhibitor screen approach to identify CXCR4 downstream signaling pathways that promote a mesenchymal and fulvestrant-resistant phenotype in breast cancer cells. Oncology Letters. 21: 380 |
| Horgan XJ, Tatum H, Brannan E, et al. (2019) Resveratrol analogues surprisingly effective against triple‑negative breast cancer, independent of ERα. Oncology Reports |
| Matossian MD, Burks HE, Elliott S, et al. (2019) Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model. Bmc Cancer. 19: 205 |
| Byrne C, Martin E, Melvin A, et al. (2019) SAT-LB055 Using Fluidics to Model the Genomic Evolution of Metastatic Breast Cancer Journal of the Endocrine Society. 3 |
| Matossian MD, Burks HE, Bowles AC, et al. (2018) A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. Breast Cancer Research and Treatment |
| Conger AK, Martin EC, Yan TJ, et al. (2016) Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation. Non-Coding Rna. 2 |
| Burks HE, Rhodes LV, Martin EC, et al. (2016) Abstract 4410: ZEB2 drives cell motility and metastasis in ER+ breast cancer cells through a novel, E-cadherin independent pathway Cancer Research. 76: 4410-4410 |
| Robert E, Rhodes LV. (2016) Abstract 3318: Exploring the utility of natural and synthetic resveratrol derivatives for bone regrowth following loss due to breast cancer therapies Cancer Research. 76: 3318-3318 |